Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 2
2014 1
2016 3
2017 3
2018 3
2019 3
2020 5
2021 1
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Inhibition of autophagy prevents cadmium-induced prostate carcinogenesis.
Pal D, Suman S, Kolluru V, Sears S, Das TP, Alatassi H, Ankem MK, Freedman JH, Damodaran C. Pal D, et al. Among authors: kolluru v. Br J Cancer. 2017 Jun 27;117(1):56-64. doi: 10.1038/bjc.2017.143. Epub 2017 Jun 6. Br J Cancer. 2017. PMID: 28588318 Free PMC article.
miR-301a expression: Diagnostic and prognostic marker for prostate cancer.
Kolluru V, Chandrasekaran B, Tyagi A, Dervishi A, Ankem M, Yan X, Maiying K, Alatassi H, Shaheen SP, C Messer J, Edwards A, Haddad A, Damodaran C. Kolluru V, et al. Urol Oncol. 2018 Nov;36(11):503.e9-503.e15. doi: 10.1016/j.urolonc.2018.07.014. Epub 2018 Sep 5. Urol Oncol. 2018. PMID: 30195463
ASR490, a Small Molecule, Overrides Aberrant Expression of Notch1 in Colorectal Cancer.
Tyagi A, Chandrasekaran B, Kolluru V, Baby BV, Sripathi CA, Ankem MK, Ramisetti SR, Chirasani VR, Dokholyan NV, Sharma AK, Damodaran C. Tyagi A, et al. Among authors: kolluru v. Mol Cancer Ther. 2020 Dec;19(12):2422-2431. doi: 10.1158/1535-7163.MCT-19-0949. Epub 2020 Oct 21. Mol Cancer Ther. 2020. PMID: 33087513 Free PMC article.
Urolithin A analog inhibits castration-resistant prostate cancer by targeting the androgen receptor and its variant, androgen receptor-variant 7.
Chandrasekaran B, Tyagi A, Saran U, Kolluru V, Baby BV, Chirasani VR, Dokholyan NV, Lin JM, Singh A, Sharma AK, Ankem MK, Damodaran C. Chandrasekaran B, et al. Among authors: kolluru v. Front Pharmacol. 2023 Mar 3;14:1137783. doi: 10.3389/fphar.2023.1137783. eCollection 2023. Front Pharmacol. 2023. PMID: 36937838 Free PMC article.
miR-301a expression: A prognostic marker for prostate cancer.
Damodaran C, Das TP, Papu John AM, Suman S, Kolluru V, Morris TJ, Faber EN, Rai SN, Messer JC, Alatassi H, Ankem MK. Damodaran C, et al. Among authors: kolluru v. Urol Oncol. 2016 Aug;34(8):336.e13-20. doi: 10.1016/j.urolonc.2016.03.009. Epub 2016 Apr 26. Urol Oncol. 2016. PMID: 27133223 Free PMC article.
22 results